Journal
JOURNAL OF CLINICAL LABORATORY ANALYSIS
Volume 24, Issue 3, Pages 123-133Publisher
WILEY
DOI: 10.1002/jcla.20350
Keywords
kinetic Jaffe method; enzymatic method; analytical performance; Commercial; glomerular filtration rate
Categories
Funding
- Mahidol University [51054/2008]
Ask authors/readers for more resources
Background: The study evaluated the impact of interferences on the analytical specificity of three commercial and commonly used creatinine methods (two Jaffe and one enzymatic). Methods: Manufacturer creatinine methods plus modified methods were tested with the following interferences: spiking serum with bilirubin, albumin, glucose, hemoglobin and lipid, and patient sera with maximum concentrations of bilirubin, 1,090 mu mol/l and protein, 117.8 g/l. Results: Hemoglobin, 7.5 g/l and lipaemic with triglyceride concentration of 6.27 mmol/l, did not interfere with all assays. Glucose >33.3 mmol/l increased creatinine recovery for Dimension method. Samples spiked with bilirubin imparted a negative bias for Dimension and Architect methods but imparted a positive bias for Vitros assay. However, using patient sera, negative bias with bilirubin was found for all methods, from which Architect method gave the highest effect (R-2 = 0.861), followed by Vitros (R-2 = 0.239) and Dimension (R-2 = 0.163). Protein provided the positive bias for all creatinine measurements that increased with increasing concentration (R2 ranging from 0.104 to 0.182, P<0.0001). Addition of sodium dodecyl sulfate (SDS) in alkaline-picrate reagent reduced the effect of bilirubin and protein for kinetic Jaffe method. Although adding potassium ferricyanide was well effective for eliminating negative interference of bilirubin, it was prone to interference from protein. Conclusions: Endogenous interferences continue to plague creatinine accuracy measurement in both Jaffe and enzymatic methods, and consequentially the estimated glomerular filtration rate. The addition of SDS to the alkaline-pirate reagent was shown to be effective in reducing bilirubin and protein interferences. J. Clin. Lab. Anal. 24:123-133, 2010. (C) 2009 Wiley-Liss, Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available